Literature DB >> 11001529

Cross-presentation: inducing CD8 T cell immunity and tolerance.

C Kurts1.   

Abstract

The term cross-presentation denotes the presentation of exogenous (extracellular) antigens to T cells, particularly CD8 T cells. It permits professional antigen-presenting cells which have collected antigens in nonlymphoid tissues to activate naive CD8 T cells in the secondary lymphatic compartment. Thus it allows CD8 T cells to scan nonlymphoid tissues for pathogens without the need of migrating there themselves and may hence be critical for immune responses to tissue-tropic viruses. It may also be essential in the immune response to nonlymphoid tumors. In contrast to the induction of immunogenic responses to pathogens, cross-presentation of self-antigens leads to CD8 T cell tolerance by deletion of autoreactive CD8 T cells. The precise way in which the immune system distinguishes self from foreign is not known, but modification in the cross-presenting antigen-presenting cell, such as that achieved by CD4 T cell help or inflammatory signals, may play a critical role in this process. If the dose of the self-antigen or the avidity of the T cell receptor is too low, cross-presentation fails to remove autoreactive CD8 T cells. Ignoring the self-antigen, these cells recirculate through the secondary lymphatics, unless they are activated, for example, by a cross-reactive virus. Then autoimmunity may be triggered.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11001529     DOI: 10.1007/s001090000108

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  9 in total

1.  Neisserial immunoglobulin A1 protease induces specific T-cell responses in humans.

Authors:  Anastasios Tsirpouchtsidis; Robert Hurwitz; Volker Brinkmann; Thomas F Meyer; Gaby Haas
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

2.  Critical role of CCL22/CCR4 axis in the maintenance of immune homeostasis during apoptotic cell clearance by splenic CD8α(+) CD103(+) dendritic cells.

Authors:  Shengyu Hao; Xiaolei Han; Dan Wang; Yang Yang; Qiuting Li; Xiangzhi Li; Chun-Hong Qiu
Journal:  Immunology       Date:  2016-03-30       Impact factor: 7.397

3.  Rejection of RG-2 gliomas is mediated by microglia and T lymphocytes.

Authors:  Christopher L Mariani; Joshua G Kouri; Wolfgang J Streit
Journal:  J Neurooncol       Date:  2006-04-13       Impact factor: 4.130

Review 4.  Immunomodulation of autoimmune diabetes by dendritic cells.

Authors:  Klaus Pechhold; Kerstin Koczwara
Journal:  Curr Diab Rep       Date:  2008-04       Impact factor: 4.810

Review 5.  T cell cross-talk with kidney dendritic cells in glomerulonephritis.

Authors:  Ulf Panzer; Christian Kurts
Journal:  J Mol Med (Berl)       Date:  2009-10-02       Impact factor: 4.599

Review 6.  Innate and adaptive immunity in experimental glomerulonephritis: a pathfinder tale.

Authors:  Katharina Artinger; Alexander H Kirsch; Ida Aringer; Foteini Moschovaki-Filippidou; Philipp Eller; Alexander R Rosenkranz; Kathrin Eller
Journal:  Pediatr Nephrol       Date:  2016-05-11       Impact factor: 3.714

Review 7.  Shaping of Peripheral T Cell Responses by Lymphatic Endothelial Cells.

Authors:  Marion Humbert; Stéphanie Hugues; Juan Dubrot
Journal:  Front Immunol       Date:  2017-01-12       Impact factor: 7.561

8.  Unveiling the Link Between Inflammation and Adaptive Immunity in Breast Cancer.

Authors:  Tadeo Enrique Velazquez-Caldelas; Sergio Antonio Alcalá-Corona; Jesús Espinal-Enríquez; Enrique Hernandez-Lemus
Journal:  Front Immunol       Date:  2019-01-29       Impact factor: 7.561

9.  Infection with the enteric pathogen C. rodentium promotes islet-specific autoimmunity by activating a lymphatic route from the gut to pancreatic lymph node.

Authors:  Sakari Pöysti; Raine Toivonen; Akira Takeda; Satu Silojärvi; Emrah Yatkin; Masayuki Miyasaka; Arno Hänninen
Journal:  Mucosal Immunol       Date:  2022-02-09       Impact factor: 7.313

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.